Patent · US Active

Transdermal carrier

US10814003B2 · kind B2 · utility

2Cited by

1References

3Claims

0Family size

Assignee

AMPERSAND BIOPHARMACEUTICALS, INC. · US

Inventors

Bruce J. Sand · Hidden Hills, US
Ryan Beal · Thousand Oaks, US
Philippe H. Burnham · Thousand Oaks, US

Key dates

Filing date	Aug 31, 2018
Grant date	Oct 27, 2020
Priority date	—
Expiry date	Aug 31, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61Q19/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Improved formulations for topical treatment that ensure at least localized transdermal or systemic delivery of an active agent through skin, nails or hair follicles are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.